| Size: 139 KB 21st Sep 2026 Number Needed to Screen for Axial Spondyloarthritis: Preliminary Results from the FASTRAX Cohort.  | Size: 141 KB 21st Sep 2026 Immunosuppressive drug use in limited systemic sclerosis: an international survey.  | Size: 158 KB 21st Sep 2026 Predicting progression of mild interstitial lung disease in systemic sclerosis: an international retrospective cohort study.  | Size: 146 KB 21st Sep 2026 Lung Transplant Outcomes in Patients with Rheumatoid Arthritis Associated Interstitial Lung Disease Compared to Idiopathic Pulmonary Fibrosis: A Multicentric Retrospective Analysis.  | Size: 146 KB 21st Sep 2026 Increased risk of intrahepatic cholestasis of pregnancy in SLE women exposed to azathioprine.  | Size: 131 KB 21st Sep 2026 Real world diagnosis and treatment of small intestinal bacterial overgrowth in systemic sclerosis: results from a multicentre retrospective descriptive study.  | Size: 154 KB 21st Sep 2026 Anti-NOR-90 autoantibodies and clinical associations in systemic sclerosis: an international retrospective cohort study  | Size: 135 KB 21st Sep 2026 Pseudotumoral Gout of the Hand: A Diagnostic Challenge.  | Size: 122 KB 21st Sep 2026 Association between early-life antibiotics and incidence of rheumatic diseases: a systematic literature review  | Size: 141 KB 21st Sep 2026 Trajectories of NT-proBNP in Systemic Lupus Erythematosus.  | Size: 126 KB 21st Sep 2026 Artificial Intelligence-based Online Symptom Assessment Tools for Systemic Lupus Erythematosus (SLE) Diagnosis: Patient Perspectives.  | Size: 139 KB 21st Sep 2026 Adverse Pregnancy Outcomes in the Lupus in prEGnAnCY (LEGACY) Cohort: Anti-Phosphatidylserine/ Prothrombin IgG Antibodies are Stronger Predictors than Lupus Anticoagulant.  | Size: 148 KB 21st Sep 2026 Maternal bleeding risk at delivery in SLE pregnancies receiving antithrombotic therapy.  | Size: 132 KB 21st Sep 2026 Anti-SRP Immune Mediated Necrotizing Myositis Masquerading as Immune Checkpoint Inhibitor-Myositis: Two Case Reports and Scoping Review of the Literature.  | Size: 100 KB 21st Sep 2026 A case of relapsing polychondritis associated meningoencephalitis.  | Size: 146 KB 21st Sep 2026 Trajectories of functional disability from Systemic Sclerosis onset: a Scleroderma Patient-centered intervention Network (SPIN) Cohort study.  | Size: 141 KB 21st Sep 2026 Drug Discontinuation in Inflammatory Arthritis Following Mandatory Non-Medical Switching from Bio-originator to Bio-similar in Quebec, Canada.  | Size: 135 KB 21st Sep 2026 Risk Factors Associated with Resistance to Multiple Biologic Agents in Psoriatic Arthritis: A Descriptive Retrospective Case-Control Cohort Study.
Next »Page 1 of « Prev


 | Size: 140 KB 21st Sep 2026 Hip-hop: A Case of Transient Osteoporosis of Both Hips.  | Size: 174 KB 21st Sep 2026 The Patient Perspective in Systemic Lupus Erythematosus (SLE) Clinical Trials: A Focus Group Study  | Size: 168 KB 21st Sep 2026 Systemic Sclerosis Mesenchymal Stromal Cells Exhibit Senescence and Profibrotic Features with Preserved Immunomodulatory and Anti-fibrotic Function.  | Size: 169 KB 21st Sep 2026 Placental Abnormalities in Systemic Lupus Erythematosus (SLE): Novel Markers for Adverse Pregnancy Outcomes.  | Size: 178 KB 21st Sep 2026 Antibiotic Prophylaxis during Treatment of ANCA-associated Vasculitis with Rituximab: Data from a Canadian Multicenter Cohort.  | Size: 171 KB 21st Sep 2026 Distinct Systemic Sclerosis Phenotypes Related to Race/Ethnicity: An Opportunity to Personalize Care?  | Size: 162 KB 21st Sep 2026 Le rôle des analyses quantitatives des scans thoraciques dans la prédiction de la progression de la maladie pulmonaire interstitielle légère associée à la sclérodermie.  | Size: 169 KB 21st Sep 2026 Update from a Living Systematic Review of the Prevalence of Mood and Anxiety Disorders and Factors Associated with Symptoms in People with Systemic Sclerosis.  | Size: 190 KB 21st Sep 2026 Adaptation and Validation of Measures to Assess Coping with Fatigue in Scleroderma: Two Scleroderma Patient-centered Intervention Network (SPIN) Cohort Studies.  | Size: 207 KB 21st Sep 2026 Differential Item Functioning on the 8-itemPatient Health Questionnaire by Disease Sub-type, Language, Sex and Age among People with Systemic Sclerosis. A Scleroderma Patient-centered Network (SPIN) Cohort Study.  | Size: 184 KB 21st Sep 2026 Identification de variants génétiques rares dans les formes familiales de la Maladie de Dupuytren.  | Size: 167 KB 21st Sep 2026 Alcohol Consumption is Associated with Spinal Radiographic Progression in Axial Spondyloarthritis.  | Size: 192 KB 21st Sep 2026 Overweight and Obesity are Key Modifiable Risk Factors for Adverse Outcomes in Systemic Lupus Erythematosus (SLE) Pregnancies.  | Size: 163 KB 21st Sep 2026 Musculoskeletal Ultrasound in Systemic Lupus Erythematosus (SLE): A Scoping Review.  | Size: 165 KB 21st Sep 2026 Patient Engagement in Rheumatic Research: State of the Evidence.  | Size: 165 KB 21st Sep 2026 Case Report: Parvovirus B19 Associated Large-vessel Vasculitis in an Immunocompromised Patient.  | Size: 163 KB 21st Sep 2026 Chained to a Diagnosis?  | Size: 162 KB 21st Sep 2026 Randomized Controlled Trial in limited Cutaneous Systemic Sclerosis: A Systematic Literature Review.
Next »Page 1 of « Prev


 | Size: 291 KB 16th Sep 2026 Improving Gout Care in a Canadian Academic Medical Centre Through a Multidisciplinary Nurse-led Program  | Size: 142 KB 16th Sep 2026 A dwarf overshadowing a giant  | Size: 202 KB 16th Sep 2026 A Special Case of Antiphospholipid Syndrome  | Size: 205 KB 16th Sep 2026 Occult Pan-Aortitis in a Patient with Reactive Arthritis  | Size: 179 KB 16th Sep 2026 Refractory Gout: A Potential Sign of a Life-Threatening Disease  | Size: 171 KB 16th Sep 2026 Conduction Disorders/Dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis  | Size: 171 KB 16th Sep 2026 Conduction Disorders/Dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis  | Size: 220 KB 16th Sep 2026 Rotavirus Vaccine in Offspring Exposed to Tumour Necrosis Factor Inhibitors Does Not Increase Diarrhea-Associated Healthcare Events: Real-World Evidence to Guide Best Practices  | Size: 190 KB 16th Sep 2026 Variants génétiques associés aux fractures atypiques des fémurs, une revue narrative de la littérature  | Size: 173 KB 16th Sep 2026 Arthritis & Cannabis Use: Evaluating Disease and Psychosocial Factors Associated With Being a Regular User  | Size: 165 KB 16th Sep 2026 Chimeric antigen receptor (CAR) T cell therapy in primary Sjögren syndrome associated non-Hodgkin lymphoma: a case report  | Size: 230 KB 16th Sep 2026 Medication-related Hospitalizations in Patients with Systemic Lupus Erythematosus  | Size: 165 KB 16th Sep 2026 Les caractéristiques radiologiques de la pneumopathie interstitielle d’apparition tardive associée à la sclérodermie systémique.  | Size: 180 KB 16th Sep 2026 Safety & immUnogenicity of COVID-19 vaCcines in systEmic immunE mediated inflammatory Diseases (SUCCEED): Preliminary Results on Severe Adverse Events  | Size: 218 KB 16th Sep 2026 Variation in tacrolimus whole blood concentrations during pregnancy and its implications for therapeutic drug monitoring: A systematic literature review  | Size: 171 KB 16th Sep 2026 Les prédicteurs de progression de la pneumopathie légère dans la sclérodermie systémique  | Size: 188 KB 16th Sep 2026 Characterization of incident interstitial lung disease in late systemic sclerosis  | Size: 219 KB 16th Sep 2026 Évolution des causes spécifiques de décès dans la maladie osseuse de Paget au Québec et comparaison à la population générale
Next »Page 1 of « Prev


 | Size: 135 KB 28th May 2019 The Differential Expression of CLEC12A on Neutrophils of Rheumatoid arthritis Patients Correlates with Clinical Parameters.  | Size: 137 KB 28th May 2019 JAK Inhibitors: a Promising Molecular-Targeted Therapy in Dermatomyositis.  | Size: 138 KB 28th May 2019 Severe Axial and Pelvi-femoral Muscle Damage in Immune-Mediated Necrotizing Myopathy evaluated by Whole-body MRI.  | Size: 133 KB 28th May 2019 Association Between Immunosuppressive Therapy and Course of Mild Interstitial Lung Disease in Systemic Scleroderma.  | Size: 135 KB 28th May 2019 No Time to Lose: A Case of Severe Multifocal Aneurysmal Vasculitis.  | Size: 134 KB 28th May 2019 Clinical Significance of Raynaud Phenomenon in Systemic Lupus Erythematosus.  | Size: 135 KB 28th May 2019 Effects of Strength Training on Participation and Health Related Quality of Life in Rheumatoid Arthritis.  | Size: 135 KB 28th May 2019 Comparison of first biologic drug persistence in patients with ankylosis spondylitis and non-radiographic axial spondyloarthritis: data from the SPARCC registry.  | Size: 136 KB 28th May 2019 Identifying Barriers and Facilitators to Physical Activity for People with Scleroderma: A Nominal Group Technique Study.  | Size: 136 KB 28th May 2019 Probability of Achieving Low Disease Activity or Remission in Subjects With Active Psoriatic Arthritis Treated With Apremilast.  | Size: 137 KB 28th May 2019 Achievement of cDAPSA Low Disease Activity or Remission Is Associated With Control of Articular and Extra-Articular Manifestations of Active Psoriatic Arthritis in Subjects Treated With Apremilast.  | Size: 138 KB 28th May 2019 Low Interstitial Lung Disease Event Rate in Patients with Rheumatoid Arthritis: Pooled Post Hoc Analysis of Data from the Tofacitinib Clinical Development Program.  | Size: 134 KB 28th May 2019 The Development of a Novel, Targeted and Less Toxic Anti-Inflammatory Drug for the Treatment of Gout.  | Size: 135 KB 28th May 2019 Characterization of the Signaling Pathway of CLEC12A: An Inhibitory Receptor involved in Gout.  | Size: 137 KB 28th May 2019 Chronic Disease Course and IV Ig-Dependence in Long-term Follow-up of Anti-HMGCR Immune-Mediated Necrotizing Myopathy.  | Size: 139 KB 28th May 2019 Physical Activity Monitoring using Wrist-Worn Accelerometer in the Assessment of Patients with Myositis.  | Size: 134 KB 28th May 2019 Resistance Training Improves Physical Function, and Body Composition in People with Rheumatoid Arthritis.  | Size: 133 KB 28th May 2019 Challenges to Optimal Rheumatology Care: A focus Group study.  | Size: 135 KB 28th May 2019 Stressful Life Events are Relation to RA Diagnosis and Presenting Characteristics: Results from the Canadian Early Arthritis Cohort (CATCH).  | Size: 137 KB 28th May 2019 Factors Influencing Patient Interest in Participating in an Online Self-care Intervention: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study.  | Size: 136 KB 28th May 2019 The Scleroderma Patient-centered Intervention Network (SPIN): Engaging Patients in Rheumatology Research.
Next »Page 1 of « Prev


 | Size: 201 KB 9th May 2018 Patterns of aspirin use in SLE pregnancies within a multinational inception cohort  | Size: 196 KB 9th May 2018 Association between Immunosuppression and Risk of New Onset Interstitial Lung Disease in Systemic Sclerosis  | Size: 199 KB 9th May 2018 Involvement of TLR-9 pathway on NK cells in Systemic Lupus Erythematosus  | Size: 196 KB 9th May 2018 Low resting energy metabolism, higher fat, and greater fatigue in sedentary patients with rheumatoid arthritis  | Size: 198 KB 9th May 2018 Building the Arthritis Alliance of Canada Quality Framework: Development of a patient-centered balanced scorecard approach to improve quality of care in rheumatoid arthritis (RA) patients in Canada  | Size: 197 KB 9th May 2018 Potential communication failures at hospital discharge may compromise SLE care  | Size: 197 KB 9th May 2018 Thick as Thieves: A curious Case of Sjögren's Syndrome  | Size: 197 KB 9th May 2018 Myosite anti PM-SCL75  | Size: 198 KB 9th May 2018 A Unique Case of Stevens–Johnson Syndrome and Giant Cell Arteritis  | Size: 196 KB 9th May 2018 Vasculite du système nerveux central à BCG  | Size: 196 KB 9th May 2018 Structure-Function Analysis of Clec12A, an Inhibitory Receptor Associated with Chronic Inflammatory Diseases  | Size: 199 KB 9th May 2018 Long-term (4-Year) Efficacy and Safety of Apremilast Monotherapy in DMARD-Naïve Subjects With Active Psoriatic Arthritis  | Size: 200 KB 9th May 2018 Consistent Safety Profile With Up to 4 Years of Apremilast Treatment: Analysis of Data From 1,493 Subjects With Psoriatic Arthritis in 3 Large, Phase III, Long-term Studies  | Size: 199 KB 9th May 2018 Characterization of Clinical Benefits in Subjects Classified as ACR20 Non-responders at Week 104 of Apremilast Treatment: Subanalysis of 3 Long-term, Phase III Trials  | Size: 200 KB 9th May 2018 Low Rates of Major Adverse Cardiac Events, Malignancies, and Serious Infections in Subjects With Psoriasis and Psoriatic Arthritis Treated With Apremilast for ≥156 Weeks: Pooled Analysis From the ESTEEM and PALACE 1-3 Phase 3 Trials  | Size: 200 KB 9th May 2018 Safety and efficacy of tofacitinib, an oral Janus kinase inhibitor, up to 36 months in patients with active psoriatic arthritis: data from the third interim analysis of OPAL Balance, an open-label, long-term extension study  | Size: 198 KB 9th May 2018 Marital status and age of systemic lupus erythematous diagnosis  | Size: 195 KB 9th May 2018 Fatigue Measurements in Systemic Lupus Erythematosus  | Size: 198 KB 9th May 2018 The Prevalence of Electrocardiographic Conduction Abnormalities in Systemic Sclerosis is very Similar to that found in Healthy Individuals: Data from the Canadian Scleroderma Research Group  | Size: 198 KB 9th May 2018 Cardiac magnetic resonance imaging role in systemic sclerosis-associated pulmonary hypertension: Analysis of 78 patients.  | Size: 197 KB 9th May 2018 aregiving intensity and perceived burden among informal caregivers of persons with systemic sclerosis compared to other chronic medical conditions  | Size: 196 KB 9th May 2018 Pulmonary Hypertrophic Osteoarthropathy in a Cystic Fibrosis Patient.  | Size: 201 KB 9th May 2018 Body Composition and Bone Health Among Sedentary Young Adults with and without Inflammatory Arthritis
Next »Page 1 of « Prev


 | Size: 50 KB 29th Mar 2018 Joint Pain in Relation to Changes in Weight and Body Composition in People Undergoing Bariatric Surgery  | Size: 52 KB 29th Mar 2018 Syndrome de Mullin  | Size: 52 KB 29th Mar 2018 Time to Pregnancy in Women with Systemic Lupus Erythematosus  | Size: 51 KB 29th Mar 2018 La maladie de Behçet intestinal  | Size: 52 KB 29th Mar 2018 The association of sociodemographic and disease variables with hand function: A Scleroderma Patient-centred Intervention Network (SPIN) Cohort study  | Size: 51 KB 29th Mar 2018 Experience with tofacitinib in Canada: Rheumatoid arthritis patient characteristics and treatment patterns from 2014 to 2016  | Size: 50 KB 29th Mar 2018 Prevalence of Joint Pain Before and After Bariatric Surgery and Impact on Physical Activity  | Size: 47 KB 29th Mar 2018 Implementation and evaluation of inflammatory arthritis models of care in Canada  | Size: 49 KB 29th Mar 2018 CLINICAL CHARACTERISTICS OF SPONDYLARTHRITIS WITH AND WITHOUT PERIPHERAL ENTHESITIS – DATA FROM THE DESIR COHORT  | Size: 50 KB 29th Mar 2018 Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-World  | Size: 48 KB 29th Mar 2018 Real-World Efficacy of Anti-TNF in Psoriatic Arthritis Patients with Enthesitis and Correlation of Enthesitis with Tender / Swollen Joints  | Size: 47 KB 29th Mar 2018 Informal Caregivers for Scleroderma Focus Groups  | Size: 47 KB 29th Mar 2018 Exploring coping strategies among people living with scleroderma through focus groups: A Scleroderma Patient-centered Intervention Network Study  | Size: 45 KB 29th Mar 2018 Subclinical Enthesopathy in Psoriatic Patients and its Relation to Other Disease Parameters: An Ultrasound Study
Next »Page 1 of « Prev


 | Size: 54 KB 4th May 2016 Corrélation d’allèles de polymorphismes nucléotidiques (SNP) dans les gènes de l’interleukine-4 (IL-4) et de son récepteur (IL-4R) et du locus CD40 avec les issues cliniques et radiographiques chez des patients avec polyarthrite inflammatoire d’installation récente traités en visant la remission  | Size: 50 KB 4th May 2016 Rheumatic and Non-Rheumatic Autoimmune Diseases in SLE Offspring  | Size: 56 KB 4th May 2016 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (104-Week) Improvement in Fatigue in Patients With Psoriatic Arthritis: Pooled Results From 3 Phase III, Randomized, Controlled Trials  | Size: 59 KB 4th May 2016 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Improves Nail and Scalp Psoriasis and PASI Scores in Patients With Moderate to Severe Plaque Psoriasis.  | Size: 63 KB 4th May 2016 Clinical and histological improvement during 5 years of treatment of a woman with Muckle-Wells Syndrome  | Size: 48 KB 4th May 2016 Le cas de madame V: une histoire qui a du piquant.  | Size: 305 KB 4th May 2016 Lorsque la polychondrite récidivante atteint les lobes d’oreille…  | Size: 44 KB 4th May 2016 Un cas de calcinose extensive.  | Size: 47 KB 4th May 2016 Single-specificity anti-Ku antibodies in a tri-nation cohort of 2140 systemic sclerosis subjects: clinical associations  | Size: 48 KB 4th May 2016 Outcomes in mothers with rheumatic diseases and their offspring workshop  | Size: 47 KB 4th May 2016 Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: a Systematic Review  | Size: 51 KB 4th May 2016 Increased Risk of Allergic Conditions in Children Born to Women with SLE  | Size: 46 KB 4th May 2016 The Scleroderma Support Group Non-Attenders Survey: A Cross-sectional Study  | Size: 43 KB 4th May 2016 Exercise Habits and Associated Factors in Scleroderma: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort Study  | Size: 51 KB 4th May 2016 Risk of Ocular Anomalies in Children Exposed in Utero to Antimalarials: Data from the Offspring of SLE mothers Registry  | Size: 43 KB 4th May 2016 Risk of Lung Cancer in Rheumatoid Arthritis Patients  | Size: 53 KB 4th May 2016 Clinical Characteristics, Laboratory Findings and Nailfold Capillaroscopy Microscopy Patterns in a Monocentric Series of 123 Patients with Idiopathic Pernio  | Size: 44 KB 4th May 2016 Malignancy in juvenile idiopathic arthritis
Next »Page 1 of « Prev


 | Size: 226 KB 6th Oct 2015 Rôle de la résolvine D1 dans la régulation des réponses inflammatoires et cataboliques de l’arthrose  | Size: 218 KB 6th Oct 2015 A novel myopathy, two very different phenotypes: the French Canadian Experience.  | Size: 228 KB 6th Oct 2015 Atorvastatin-Induced Autoimmune Myopathy: An Emerging Dominant Entity in Patients with Autoimmune Myopathy Presenting with a Pure Polymyositis Phenotype.  | Size: 223 KB 6th Oct 2015 The anti-MDA5 autoantibody phenotype: Defining clinical, biochemical and radiological features suggestive of anti-MDA5-associated rapidly progressive interstitial lung disease.  | Size: 242 KB 6th Oct 2015 CRP and 14-3-3η are each associated with joint damage progression, their titres do not correlate and are better predictors of progression together than alone.  | Size: 229 KB 6th Oct 2015 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (52-Week) Improvements in Enthesitis and Dactylitis in Patients With Psoriatic Arthritis: Pooled Results From Three Phase III, Randomized, Controlled Trials.  | Size: 230 KB 6th Oct 2015 Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational Registry, BioTRAC.  | Size: 221 KB 6th Oct 2015 Folate Supplementation and Cancer Risk in Rheumatoid Arthritis Patients Exposed to Methotrexate.  | Size: 221 KB 6th Oct 2015 Arthritis, gender, disability and incidence of Coronary Heart Disease: A longitudinal Canadian population-based cohort study.  | Size: 219 KB 6th Oct 2015 Alterations of the Non-Canonical WNT/PKC Pathway in Human Osteoarthritis Osteoblasts.  | Size: 227 KB 6th Oct 2015 Prevalence, Severity and Impact of Fecal Incontinence in Systemic Sclerosis: Preliminary Results of a Cross-Sectional Study.  | Size: 220 KB 6th Oct 2015 Resveratrol Regulates the WNT/ ß-Catenin Pathway in Human Osteoaarthritis Osteoblasts.  | Size: 221 KB 6th Oct 2015 Demographic and Disease Correlates of Clinically Significant Fatigue in Systemic Sclerosis: Preliminary Evidence Using Case-Definition Criteria.  | Size: 220 KB 6th Oct 2015 Sociodemographic and Disease Correlates of Fatigue in Systemic Sclerosis.  | Size: 220 KB 6th Oct 2015 Focus groups to inform the development of a scleroderma emotional distress coping tool.  | Size: 220 KB 6th Oct 2015 Risk of Breast, Ovarian and Endometrial Cancers in Women with Rheumatoid Arthritis.  | Size: 219 KB 6th Oct 2015 Breast, Ovarian and Endometrial Cancer in Women Diagnosed with SLE Before Age 40.  | Size: 214 KB 6th Oct 2015 Une polyarthrite chronique révélant une lèpre.
Next »Page 1 of « Prev


 | Size: 229 KB 26th Jan 2016 Further Reduction in Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With up to 7 Years in the FREEDOM Extension.  | Size: 231 KB 26th Jan 2016 Could Estrogen Impact a New Pertinent Gene for Adolescent Idiopathic Scoliosis (AIS)?  | Size: 235 KB 26th Jan 2016 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-term (52-Week) Improvement in Swollen and Tender Joint Counts in Patients With Psoriatic Arthritis: Results From Three Phase 3, Randomized, Controlled Trials.  | Size: 226 KB 26th Jan 2016 The pan-Canadian Approach to Inflammatory Arthritis Models of Care. Michel Zummer  | Size: 233 KB 26th Jan 2016 Depressive Symptoms at Baseline Predict Higher Simple Disease Activity Index (SDAI) Scores and Longer Time to Remission in Patients with Recent-Onset Arthritis.  | Size: 227 KB 26th Jan 2016 Ultrasound Doppler activity correlates with systemic autoimmunity and swollen joints in a healthy population at risk for rheumatoid arthritis.  | Size: 230 KB 26th Jan 2016 Redefining Dermatomyositis: Description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.  | Size: 224 KB 26th Jan 2016 Sous hypoxie, les fibroblastes synoviaux sains et arthritiques révèlent des altérations du métabolisme des sphingolipides.  | Size: 233 KB 26th Jan 2016 Laboratory Abnormalities in Patients With Psoriatic Arthritis Receiving Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials.  | Size: 232 KB 26th Jan 2016 What investigations are needed to optimally monitor for malignancies in SLE?  | Size: 224 KB 26th Jan 2016 Management of fragility fracture: an integrated interdisciplinary approach.  | Size: 232 KB 26th Jan 2016 The role of marital satisfaction in emotional distress among women with scleroderma.  | Size: 229 KB 26th Jan 2016 Anti-Ro antibodies and cancer in Systemic Lupus Erythematosus.  | Size: 231 KB 26th Jan 2016 An international collaboration to conduct large-scale trials of non-pharmacological interventions in scleroderma: the Scleroderma Patient-centered Intervention Network (SPIN).  | Size: 246 KB 26th Jan 2016 Recurrent hypocalcemia following denosumab in a patient with short bowel and renal impairment.  | Size: 235 KB 26th Jan 2016 Can scores from English, French and Dutch versions of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) be pooled? An assessment of differential item functioning in patients with systemic sclerosis.  | Size: 230 KB 26th Jan 2016 Lien entre l’antagoniste DKK2 et la réponse à la PTH par les ostéoblastes humains ostéoarthrosiques.  | Size: 225 KB 26th Jan 2016 Estrogen receptor status and transcriptome profiling of genes regulated by 17-beta estradiol in human osteoblasts derived from idiopathic scoliosis patients.  | Size: 227 KB 26th Jan 2016 PPAR Υ controls mTOR/autophagy signalling in the articular cartilage. Faezeh Vasheghani Farahan  | Size: 227 KB 26th Jan 2016 LSD1-Mediated Demethylation of Histone H3 Lysine 9 Contributes to Interleukin 1-Induced Microsomal Prostaglandin E Synthase-1 Expression in Human Osteoarthritic Chondrocytes.
Next »Page 1 of « Prev


 | Size: 226 KB 27th Jan 2016 Les effets paradoxaux des agents anti-TNF  | Size: 225 KB 27th Jan 2016 Joint Action on Arthritis: A Framework to Improve Arthritis Prevention and Care in Canada.  | Size: 239 KB 27th Jan 2016 Denosumab Compared with Risedronate in Postmenopausal Women Suboptimally Adherent with Alendronate Therapy: Efficacy and Safety Results from a Randomized Open-Label Study.  | Size: 224 KB 27th Jan 2016 One-Year Results from the Canadian CAMEO Study: A Trial of Etanercept and Methotrexate versus Etanercept Alone in Rheumatoid Arthritis.  | Size: 230 KB 27th Jan 2016 The role of toll-like receptor-4 (TLR-4) activation in a murine model of systemic lupus erythematosus (SLE).  | Size: 233 KB 27th Jan 2016 Hypoxia in human osteoarthritic subchondral bone: a risk factor for leptin production by osteoblasts.  | Size: 232 KB 27th Jan 2016 Metabolic Factors, Biomechanical Stress and Estrogen Impact on Osteoblasts.  | Size: 238 KB 27th Jan 2016 Induced Abortions in Women with Systemic Sclerosis.  | Size: 229 KB 27th Jan 2016 A roadmap to personalized medicine in Rheumatoid Arthritis using anti-Sa antibody titers to monitor the immunopathologically driven, clinical disease activity.  | Size: 240 KB 27th Jan 2016 An Autoimmune Myositis-Overlap Syndrome Associated with Autoantibodies to Nuclear Pore Complexes. Description and Long-Term Follow-Up of the Anti-Nup Syndrome.  | Size: 226 KB 27th Jan 2016 Rheumatoid Arthritis Prevalence in Quebec.  | Size: 236 KB 27th Jan 2016 Measurement of Pulmonary Arteries by Cardiac Magnetic Resonance Imaging: A Simple and Useful Tool for the Detection of Pulmonary Hypertension in Systemic Sclerosis Patients without Overt Cardiac Microvascular Perfusion Defects or Fibrosis.  | Size: 233 KB 27th Jan 2016 Effects of Vitamin D Repletion and Maintenance Therapy on RA Characteristics and Quality of Life.  | Size: 234 KB 27th Jan 2016 Gender and Time to Diagnosis in Systemic Sclerosis: An Updated Analysis of 1,129 Patients from the Canadian Scleroderma Research Group Registry  | Size: 228 KB 27th Jan 2016 Expression of PPARa, b, g, and H- and L-PGDS during Osteoarthritis in the Spontaneous Hartley Guinea Pig and the Experimental Dog Models  | Size: 241 KB 27th Jan 2016 Low Prevalence of Myocardial Fibrosis by Cardiac Magnetic Resonance Imaging in 39 French Canadian Systemic Sclerosis Patients: Comparison of the CHUM Cohort with other World Cohorts.  | Size: 237 KB 27th Jan 2016 Prevalence of Current, 12-Month, and Lifetime Major Depressive Disorder among Patients with Systemic Sclerosis.  | Size: 233 KB 27th Jan 2016 Targeting fear of disease progression in rheumatic diseases: a case study in systemic sclerosis.  | Size: 226 KB 27th Jan 2016 H3K9 demethylation by LSD1 contributes to IL-1-induced mPGES-1 expression in OA chondrocytes.  | Size: 233 KB 27th Jan 2016 Increased Body Mass Index Among RA Patients.  | Size: 230 KB 27th Jan 2016 Inducible cartilage-specific PPARgamma-deficient mice exhibit accelerated experimentally-induced osteoarthritis associated with defective autophagy and mTOR signaling.  | Size: 229 KB 27th Jan 2016 Low Sirtuin 1 levels in human Osteoarthritis Subchondral Osteoblasts lead to abnormal Sclerostin expression which decreases Wnt/β-catenin activity.  | Size: 227 KB 27th Jan 2016 Clinically Apparent Arterial Thrombosis in Persons with Systemic Vasculitis.
Next »Page 1 of « Prev